Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Kapito RobertDirector, President | Grant or award | A | — 5,127 sh | Jan 21, 2026 |
| 15 | Blackwood Lindsay K.SVP, Gen Counsel & Secretary | Grant or award | A | — 2,720 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Macdonald AndrewSee Remarks | Option exercise | M | — 3,841 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Krishnamurthy NikkiSVP and Chief People Officer | Option exercise | M | — 2,001 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Mills Desmond JSVP & Chief Accounting Officer | Option exercise | M | — 1,367 sh | Jan 21, 2026 traded Jan 18, 2026 |
| 15 | Brooke Beth A.Director | Grant or award | A | — 48 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Wagner SusanDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Trahan JeremyGeneral Counsel | Option exercise | M | — 4,884 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 13 | Heitz Michael JohnChief Financial Officer | Tax withholding | F | $21K 636 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 13 | Sanden BlayneSVP & PAO | Grant or award | A | $24K 750 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 13 | Bluestone JeffreyDirector | Option exercise · 10b5-1 plan | M | $337K 5,000 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 13 | Wagner ScottDirector | Option exercise | M | — 31.4K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | Olmstead NathanSVP and CFO | Tax withholding | F | $60K 2,988 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | DeSantis Dean10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Smith DironEVP, Chief Financial Officer | Tax withholding | F | $73K 848 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Baur Frank TobiasEVP, Chief Operating Officer | Tax withholding | F | $50K 716 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Marquez OctavioDirector, President and CEO | Tax withholding | F | $219K 3,136 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Radigan Elizabeth ChristineEVP, Chief Administrative Ofcr | Tax withholding | F | $53K 757 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Kuykendall AnneSVP and Chief Legal Officer | Tax withholding | F | $67K 3,379 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | Milmoe William H.10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | Milmoe William H.10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $23K 396 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 12 | DeSantis Dean10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | Clark Joseph GatesSVP and Pres, Optimized LED | Tax withholding | F | $51K 2,564 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Myers JonathanEVP, Chief Revenue Officer | Tax withholding | F | $73K 1,047 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 11 | Piekos BrianChief Financial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Smith DironEVP, Chief Financial Officer | Grant or award | A | — 7,091 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Issa Mohamed KhairieEVP, Head of US Oncology | Grant or award | A | — 14.2K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Tray ThomasPrincipal Accounting Officer | Grant or award | A | — 2,425 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $28K 1,440 sh | Jan 21, 2026 traded Jan 21, 2026 |
| 11 | Okupe OluyemiChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $275K 9,067 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 11 | Small MartinCFO & Senior Managing Director | Option exercise | M | — 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Sweeny NicoleChief Commercial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Grant or award | A | — 4,218 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Audhya Paul K.CHIEF MEDICAL OFFICER | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 10 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 6.60M sh | Jan 21, 2026 traded Jan 16, 2026 |
| 10 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $31K 200 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 10.2K sh | Jan 21, 2026 traded Jan 19, 2026 |